Trial intelligence / Profile preview

Ozonated Oil Dressing for Early Wound Inflammation After Inguinal Hernia Repair

NCT07328698Recruiting

Sponsor
Niğde Ömer Halisdemir University
Start
Feb 2026
Primary completion
Apr 2026
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

Randomised, single-blind trial of ozonated oil in surgical site infection (SSI) (2 arms), sponsored by Niğde Ömer Halisdemir University. Primary endpoint: Composite Wound Inflammation Score at Day 3. Started Feb 2026; status: recruiting.

02

Drugs

ozonated oil
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT07328698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07328698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call